| Control | Cases (Group I) | Cases (Group II) | p Value |
Age | 44.81 ± 10.70 | 50.88 ± 9.39 | 50.40 ± 11.20 | 0.049 |
BMI | 24.29 ± 3.70 | 27.23 ± 4.37 | 25.87 ± 3.20 | 0.019 |
HTN | 6 (14.3%) | 7 (41.2%) | 11 (44%) |
|
Smoking | 11 (26.2%) | 2 (11.8%) | 1 (4%) |
|
FHD | 2 (4.8%) | 0 (0%) | 1 (4%) |
|
TC | 164.31 ± 40.61 | 162.07 ± 40.67 | 176.57 ± 27.11 | 0.40 |
TG | 151.94 ± 67.13 | 163.73 ± 52.29 | 182.20 ± 51.11 | 0.20 |
LDL | 94.11 ± 32.27 | 99.80 ± 26.35 | 109.40 ± 26.54 | 0.19 |
HDL | 40.37 ± 10.7 | 37.80 ± 8.63 | 36.95 ± 6.47 | 0.37 |
Aspirin | 13 (31%) | 5 (29.4%) | 7 (28%) | 1.00 |
Clopidogrel | 7 (16.7%) | 2 (11.8%) | 2 (8%) | 0.701 |
Statin | 17 (40.5%) | 16 (94.1%) | 24 (96%) | <0.001 |
B blockers | 18 (42.9%) | 7 (41.2%) | 7 (28%) | 0.460 |
FBSS (mg/dl) | 5.47 ± 0.61 | 7.74 ± 2.56 | 6.81 ± 1.89 | <0.001 |
Insulin (µ U/dl) | 11.58 ± 6.38 | 13.26 ± 8.09 | 6.65 ± 2.36 | <0.001 |
Homa-IR | 2.50 ± 1.25 | 4.98 ± 2.23 | 1.85 ± 0.56 | <0.001 |